|
1
|
Karlsson I, Traub S, Järås K, Edwards D, Gramming E, Lindell Andersson M, To Y, Mårtensson L, Teige I, Acton G, Dyer M, Radford J, Collins G, Jerkeman M, Frendéus B, McAllister A, Davies A. PHASE 1/2A CLINICAL TRIALS OF BI-1206, A MONOCLONAL ANTIBODY TO FCΓRIIB, ADMINISTERED AS A SINGLE AGENT OR IN COMBINATION WITH RITUXIMAB IN SUBJECTS WITH B-CELL MALIGNANCIES. Hematol Oncol 2019. [DOI: 10.1002/hon.206_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- I. Karlsson
- Preclinical Research; BioInvent International AB; Lund Sweden
| | - S. Traub
- Centre for Drug Development; Cancer Research UK; London United Kingdom
| | - K. Järås
- Clinical Development; BioInvent International AB; Lund Sweden
| | - D. Edwards
- Centre for Drug Development; Cancer Research UK; London United Kingdom
| | - E. Gramming
- Clinical Development; BioInvent International AB; Lund Sweden
| | | | - Y. To
- Centre for Drug Development; Cancer Research UK; London United Kingdom
| | - L. Mårtensson
- Preclinical Research; BioInvent International AB; Lund Sweden
| | - I. Teige
- Preclinical Research; BioInvent International AB; Lund Sweden
| | - G. Acton
- Centre for Drug Development; Cancer Research UK; London United Kingdom
| | - M.J. Dyer
- Ernest and Helen Scott Haematological Research Institute; University of Leicester; Leicester United Kingdom
| | - J. Radford
- Institute of Cancer Sciences; University of Manchester; Manchester United Kingdom
| | - G.P. Collins
- Oxford Cancer and Haematology Centre; Churchill Hospital; Oxford United Kingdom
| | - M. Jerkeman
- Department of Oncology; Skane University Hospital; Lund Sweden
| | - B. Frendéus
- Preclinical Research; BioInvent International AB; Lund Sweden
| | - A. McAllister
- Clinical Development; BioInvent International AB; Lund Sweden
| | - A. Davies
- University of Southampton; Cancer Research UK Centre; Southampton United Kingdom
| |
Collapse
|
|
2
|
Hvid H, Teige I, Kvist PH, Svensson L, Kemp K. TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis. Int Immunol 2008; 20:1097-106. [DOI: 10.1093/intimm/dxn068] [Citation(s) in RCA: 53] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
|
|
3
|
Matheu V, Treschow A, Teige I, Barrios Y, Issazadeh-Navikas S. Role of IFN-beta gene in the immune response after CpG motifs treatment in an allergy murine model. J Allergy Clin Immunol 2003. [DOI: 10.1016/s0091-6749(03)81162-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
|
4
|
Vik T, Hagen KB, Teige I. [Occupational environment and health status of lumberjacks]. Tidsskr Nor Laegeforen 1984; 104:2473-6. [PMID: 6523477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
|